MT2019-09: A randomized trial of low versus moderate exposure busulfan for infants with severecombined immunodeficiency (SCID) receiving TCR????+/CD19+ depleted transplantation: A Phase II studyby the Primary Immune Deficiency Treatment Consortium (PID

Project: Research project

Project Details

Description

MT2019-09: A randomized trial of low versus moderate exposure busulfan for infants with severe combined immunodeficiency (SCID) receiving TCR????+/CD19+ depleted transplantation: A Phase II study by the Primary Immune Deficiency Treatment Consortium (PID
StatusActive
Effective start/end date8/16/195/31/24

Funding

  • CHILDREN'S HOSPITAL LOS ANGELES

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.